Vineti achieves SOC2 Type II compliance
Vineti Blog
by
1y ago
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC ..read more
Visit website
Vineti introduces new PTM® Integration Suite: purpose-built connectivity and interoperability for cell and gene therapies
Vineti Blog
by
1y ago
Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a cornerstone of its Personalized Therapy ..read more
Visit website
Vineti’s Personalized Therapy Management® (PTM) solution meets rigorous standards: Service Organization Control (SOC®) 2 Type II compliance audit
Vineti Blog
by
1y ago
Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a cornerstone of its Personalized Therapy ..read more
Visit website
Vineti Appoints Ann Klein as Chief Executive Officer
Vineti Blog
by
1y ago
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC ..read more
Visit website
Cell and gene therapies – new treatments, new value
Vineti Blog
by
1y ago
At the recent Gene Therapy for Rare Disorders conference in Boston, I had the opportunity to discuss thoughts on value with an audience dedicated to ..read more
Visit website
Gene therapies – simpler doesn’t mean simple
Vineti Blog
by
1y ago
Cell and gene therapies are produced and delivered via the most complex workflows in the history of medicine. Among those workflows, though, there’s a range ..read more
Visit website
Vineti secures new patent from USPTO for individualized medicine platform
Vineti Blog
by
1y ago
SAN FRANCISCO, March ##, 2022 (GLOBE NEWSWIRE) – Vineti, Inc., the provider of the leading digital platform of record for cell and gene therapies, today ..read more
Visit website
SedApta Group and Vineti partner to develop integrated digital supply chain and manufacturing solution for cell and gene therapies
Vineti Blog
by
1y ago
The sedApta Group, a global software provider specialized in innovative IT solutions for digital Supply Chain and Smart Manufacturing, and Vineti, the provider of the ..read more
Visit website
Cell and gene therapies: the necessity of a purpose-built platform
Vineti Blog
by
1y ago
Given the wide array of CRMs and other digital systems already serving healthcare and biopharma, that reality might sound like overkill. But after more than ..read more
Visit website
New FDA guidance: cell therapies and patient identifiers
Vineti Blog
by
1y ago
When the US Food and Drug Administration (FDA) recently made two draft guidance documents for the cell and gene therapies available for comment, the Vineti ..read more
Visit website

Follow Vineti Blog on FeedSpot

Continue with Google
Continue with Apple
OR